Healthy Me: A Program for Older Women
Changes in Weight and Physical Function for Older African American Women in a National, Nonprofit, Community-Based, Peer-Led, Weight Loss Program
2 other identifiers
interventional
116
1 country
1
Brief Summary
The first phase of the study is a feasibility survey of eligible participants, completed prior to initiating the intervention. The intervention consists of a 6-month 1:1 randomized trial with a waitlist control that recruits 120 older AA women. The rationale for these aims is that the successful completion is expected to provide evidence that a community-based, peer-led weight loss program with a national infrastructure can help a vulnerable, underserved population lose weight and improve their physical function. For older, obese, frail individuals, this could improve their CVD risk factors, quality of life, enhance their health; reduce their healthcare utilization, illness, and disability; and decrease their adverse geriatric outcomes. After completing these aims, the investigators expect that they will have proven that the community-based, peer-led weight loss program can improve both weight and physical function among older, obese AA women. This also could help other demographic groups with obesity and poor physical function. Eventually, it could help older adults maintain their health and independence in the community
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2019
CompletedFirst Posted
Study publicly available on registry
February 18, 2019
CompletedStudy Start
First participant enrolled
May 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 17, 2025
CompletedResults Posted
Study results publicly available
May 20, 2026
CompletedMay 20, 2026
April 1, 2026
1.7 years
January 29, 2019
January 6, 2026
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight Change
Percent of body weight change over 6 months
Baseline to 6 months
Secondary Outcomes (25)
Systolic Blood Pressure (BP)
Baseline, 3 months, 6 months
Diastolic Blood Pressure (BP)
Baseline, 3 months, 6 months
Waist Circumference (WC)
Baseline, 3 months, 6 months
Hemoglobin A1c (HA1c)
Baseline, 3 months, 6 months
HDL (High-Density Lipoprotein) Cholesterol
Baseline, 3 months, 6 months
- +20 more secondary outcomes
Study Arms (2)
Take Off Pounds Sensibly (TOPS)
EXPERIMENTALThis group will receive TOPS intervention at the start of the study.
Waitlist control
OTHERThis group will be the control group for 6 months. Then at the completion of the study they will receive the vouchers to participate in TOPS chapters in the community.
Interventions
Dietitian-facilitated classes
Eligibility Criteria
You may qualify if:
- African American women aged ≥55
- BMI ≥27 kg/m2
- Stable body weight (± 2 kg for 6 months prior to study)
- Sedentary (not exercising more than 1 hour per week)
- Must have a primary care provider and provide contact information
- Participants with type 2 diabetes on insulin or sulfonylureas will be allowed to participate in the study only if their providers agree to manage the changing medications requirements associated with possible weight loss by signing a "Permission to Participate" form. It is important to include patients with type 2 diabetes on insulin and sulfonylureas because these participants can benefit greatly from weight loss.
You may not qualify if:
- Type 2 diabetes on insulin or sulfonylureas without provider approval
- current cancer diagnosis
- Provider did not approve participation
- use of medications thought to effect metabolism, body weight, energy expenditure, or appetite
- major psychiatric disorder
- current moderate to severe symptoms of depression
- dementia
- neurological conditions causing functional limitations
- unstable medical illness such as unstable angina, recent MI, or congestive heart failure class III-IV
- terminal medical conditions
- Currently enrolled in a weight loss program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Duke University
Durham, North Carolina, 27707, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nia Schwann Mitchell, MD, MPH
- Organization
- Duke University
Study Officials
- PRINCIPAL INVESTIGATOR
Nia S Mitchell, MD, MPH
Duke University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2019
First Posted
February 18, 2019
Study Start
May 17, 2023
Primary Completion
January 17, 2025
Study Completion
January 17, 2025
Last Updated
May 20, 2026
Results First Posted
May 20, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share